LIFE Biosystems GmbH announced today that it has entered into a collaborative agreement with the Department of Bioinformatics at the Fraunhofer Institute for Algorithms and Scientific Computing SCAI.
As part of this agreement, LIFE has licensed the ProMiner entity recognition software, which will become an integral part of LIFE's text-mining infrastructure. In addition, both parties will work to collaboratively advance the development of information extraction algorithms in the clinical research domain. These efforts will focus on the identification and modelling of therapeutically relevant information from clinical/lexical data, with particular emphasis on drug mode of action and clinical outcomes.
"We have been extremely impressed by the advances made by SCAI in the field of biological information extraction" stated Dr. David Jackson, Director of in silico Discovery at LIFE Biosystems. "The synergies created as a result of this collaboration will enable us to efficiently bridge the gap between the clinical and molecular information domains. In so doing, we aim to achieve a new level of innovation in the analysis and application of patient derived data".
"The collaboration with LIFE Biosystems fits perfectly with our overall strategy to further develop our text-mining technologies for application areas beyond biology" says Dr. Juliane Fluck, Head of the Text Mining Group at Fraunhofer SCAI. "The domain of clinical information requires dedicated solutions for information extraction and the collaboration with LIFE Biosystems will help us to develop specialized ProMiner functionalities supporting mining in unstructured clinical data".
ABOUT LIFE BIOSYSTEMSLIFE Biosystems is an in silico-driven discovery company dedicated to the field of predictive medicine. Working together the biopharmaceutical industry and comprehensive cancer centers, we strive to address the key issues facing clinical research and therapeutic development today. As expert practitioners of in silico discovery in molecular medicine, our goal is to transform patient information and molecular data into a new level of clinical discovery, intellectual property and ultimately, patient benefit. For additional information about the company, please visit:
Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung
New Master’s programme: University of Kaiserslautern educates experts in quantum technology
15.03.2017 | Technische Universität Kaiserslautern
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...
Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
20.09.2017 | Life Sciences
20.09.2017 | Power and Electrical Engineering
20.09.2017 | Physics and Astronomy